Your session is about to expire
← Back to Search
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 18 months (baseline and post-study)
Awards & highlights
Study Summary
This trial is testing a method to help patients with diabetes get access to services that can help them manage their condition.
Who is the study for?
This trial is for clinic staff at participating clinics, focusing on using technology and support to improve referrals of diabetes patients to self-management education services. There are no specific exclusions except that participants must be employed at a participating clinic.Check my eligibility
What is being tested?
The study tests two methods: 'UP FOR IT - health information technology' and 'UP FOR IT - practice facilitation', aiming to overcome referral barriers and boost clinician engagement in referring diabetes patients for self-management education.See study design
What are the potential side effects?
Since this trial involves organizational interventions rather than medical treatments, it does not have traditional side effects. However, there may be indirect impacts on workflow or time management within the clinics.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 18 months (baseline and post-study)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~18 months (baseline and post-study)
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in DSMES Referrals
Secondary outcome measures
Change in A1c Levels
Change in DSMES Attendance
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention ClusterExperimental Treatment2 Interventions
Clinics in the intervention group will participate in the 12-month intervention which incorporates health information technology and practice facilitation.
Group II: Control ClusterActive Control1 Intervention
Clinics in the control group will only be provided with health information technology; they will not participate in the 12-month intervention which incorporates health information technology and practice facilitation.
Find a Location
Who is running the clinical trial?
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH
2,356 Previous Clinical Trials
4,315,044 Total Patients Enrolled
106 Trials studying Diabetes
138,641 Patients Enrolled for Diabetes
Mary LacyLead Sponsor
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:Research Study Groups:
This trial has the following groups:- Group 1: Control Cluster
- Group 2: Intervention Cluster
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is enrollment still open for this investigation?
"Affirmative. According to details hosted on clinicaltrials.gov, this medical study has been open for recruitment since March 1st 2023 and was last updated 6 days ago. 65 participants are needed across a single site."
Answered by AI
How many participants are encompassed by this scientific research?
"Affirmative. Clinicaltrials.gov holds information that this clinical trial is currently enlisting patients, having been initially posted on March 1st 2023 and last revised on the 6th of March 2023. 65 individuals need to be enrolled at a single site."
Answered by AI
Share this study with friends
Copy Link
Messenger